Guangxi Liuzhou Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
March 29, 2021 at 10:24 am EDT
Share
Guangxi Liuzhou Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 15,668.662 million compared to CNY 14,856.825 million a year ago. Operating income was CNY 904.625 million compared to CNY 896.585 million a year ago. Net income was CNY 711.713 million compared to CNY 685.426 million a year ago. Basic earnings per share from continuing operations was CNY 1.96 compared to CNY 1.89 a year ago.
Guangxi LiuYao Group Co Ltd, formerly Guangxi Liuzhou Pharmaceutical Co Ltd, is a China-based company mainly engaged in the sales of pharmaceuticals. The Company is mainly engaged in three businesses. The pharmaceutical wholesale business mainly distributes pharmaceutical products to medical and health institutions at all levels, pharmaceutical distribution enterprises and chain pharmacies. The pharmaceutical retail business provides sales and health services of various pharmaceutical products, medical devices and other pharmaceutical products to individual consumers through terminal pharmacies. The pharmaceutical industry business is mainly engaged in the production and processing of traditional Chinese medicine pieces and traditional Chinese medicine formula granules. The Company is also engaged in supply chain value-added services, pharmaceutical Internet services, terminal health services and others.
GUANGXI LIUYAO GROUP CO., LTD 
